Regarding management, 37.8% of participants were treated with oral hypoglycemic agents, 24.2% with insulin injections, 22% with a combination of oral agents and insulin, and 16% managed their diabetes through dietary modification alone. The gene discussed is INS; the disease is diabetes mellitus.